Pivotal bioVenture Partners Investment Advisor

Latest statistics and disclosures from Pivotal bioVenture Partners Investment Advisor's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are KRTX, PCVX, RLYB, FUSN, EXAI, and represent 82.49% of Pivotal bioVenture Partners Investment Advisor's stock portfolio.
  • Added to shares of these 2 stocks: EXAI (+$11M), Vigil Neuroscience.
  • Started 2 new stock positions in EXAI, Vigil Neuroscience.
  • Reduced shares in these 2 stocks: PCVX (-$7.1M), FUSN.
  • Pivotal bioVenture Partners Investment Advisor was a net buyer of stock by $8.0M.
  • Pivotal bioVenture Partners Investment Advisor has $211M in assets under management (AUM), dropping by -25.30%.
  • Central Index Key (CIK): 0001844645

Tip: Access up to 7 years of quarterly data

Positions held by Pivotal bioVenture Partners Investment Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor

Companies in the Pivotal bioVenture Partners Investment Advisor portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Karuna Therapeutics Ord (KRTX) 51.2 $108M 853k 126.79
Vaxcyte (PCVX) 12.7 $27M -20% 1.1M 24.15
Rallybio Corp (RLYB) 7.5 $16M 2.3M 6.98
Fusion Pharmaceuticals (FUSN) 5.9 $12M 1.6M 7.77
Exscientia Ads (EXAI) 5.3 $11M NEW 772k 14.40
Arcutis Biotherapeutics (ARQT) 5.2 $11M 569k 19.26
Akouos (AKUS) 4.0 $8.5M 1.8M 4.75
Inozyme Pharma (INZY) 3.1 $6.5M 1.6M 4.09
Bolt Biotherapeutics (BOLT) 2.5 $5.2M 1.9M 2.74
Vigil Neuroscience 1.9 $3.9M NEW 561k 7.03
Aligos Therapeutics (ALGS) 0.9 $1.9M 877k 2.15

Past Filings by Pivotal bioVenture Partners Investment Advisor

SEC 13F filings are viewable for Pivotal bioVenture Partners Investment Advisor going back to 2020